Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases

• 收藏
• 分享

专利权人:

EXELIXIS INC.

发明人:

SMITH DAVID,HUSSAIN MAHA

申请号：

NZ70793011

公开号：

NZ707930A

申请日:

2011.09.26

申请国别(地区):

NZ

年份:

2016

代理人:

摘要：

The disclosure relates to methods for treating bone cancer, prostate cancer or bone cancer associated with prostate cancer, comprising administering a compound that dually modulates MET and VEGF. In particular, the methods are for treating castration-resistant prostate cancer (CRPC) and osteoblastic bone metastases and centres. The compound (compound I - cabozantinib) contains a quinolone, dicarboxamide and a cyclopropane functional groups.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/